0000819050-22-000151.txt : 20221007 0000819050-22-000151.hdr.sgml : 20221007 20220907164602 ACCESSION NUMBER: 0000819050-22-000151 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20220907 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Fresh Tracks Therapeutics, Inc. CENTRAL INDEX KEY: 0000819050 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 930948554 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 5777 CENTRAL AVENUE STREET 2: SUITE 102 CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: (720) 505-4755 MAIL ADDRESS: STREET 1: 5777 CENTRAL AVENUE STREET 2: SUITE 102 CITY: BOULDER STATE: CO ZIP: 80301 FORMER COMPANY: FORMER CONFORMED NAME: Brickell Biotech, Inc. DATE OF NAME CHANGE: 20190830 FORMER COMPANY: FORMER CONFORMED NAME: VICAL INC DATE OF NAME CHANGE: 19940211 CORRESP 1 filename1.htm Document

September 7, 2022


VIA EDGAR

Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549

Re:    Fresh Tracks Therapeutics, Inc.
Registration Statement on Form S-1
File Number 333-267254

Ladies and Gentlemen:

Fresh Tracks Therapeutics, Inc. (the “Company”) hereby requests that the effectiveness of the above-referenced registration statement on Form S-1 be accelerated so that it will become effective at 4:00 p.m. Eastern time on September 9, 2022, or as soon thereafter as practicable.

Please telephone the undersigned (720-505-4755) or Jonathan R. Zimmerman of Faegre Drinker Biddle & Reath LLP (612-766-8419) if you have any questions with respect to the foregoing.
 Very truly yours, 
 
FRESH TRACKS THERAPEUTICS, INC.
 
 By:/s/ Robert B. Brown 
  Name: Robert B. Brown 
  Title: Chief Executive Officer